Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-005090-22Phase 2Unknown
Phase 2, randomised trial in giant cell arteritis (GCA) comparing Delayed-release Lodotra with Immediate-release prednisolone (2 arms). Primary endpoint: Persistent disease control and flare-free status at 26 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-005090-22.